Literature DB >> 11818324

Comparative study of KL-6, surfactant protein-A, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases.

Hiroshi Ohnishi1, Akihito Yokoyama, Keiichi Kondo, Hironobu Hamada, Masahiro Abe, Kazutaka Nishimura, Kunio Hiwada, Nobuoki Kohno.   

Abstract

KL-6, surfactant protein (SP)-A, SP-D, and monocyte chemoattractant protein-1 (MCP-1) are reported to be sensitive markers for interstitial lung diseases (ILD). However, each marker has been studied independently. The aim of this study was a comparative analysis of the diagnostic values of these markers. Subjects consisted of 33 patients with ILD (21 cases of idiopathic pulmonary fibrosis and 12 associated with collagen vascular diseases) and 82 control subjects (12 cases of bacterial pneumonia and 70 healthy volunteers). Receiver operating characteristic curves revealed that KL-6 was superior to the other markers. The cut-off levels for these markers that resulted in the highest diagnostic accuracy were determined to be 465 U/ml for KL-6, 48.2 ng/ml for SP-A, 116 ng/ml for SP-D, and 1080 pg/ml for MCP-1. The sensitivity, specificity, and diagnostic accuracy were 93.9%, 96.3%, and 95.7% for KL-6; 81.8%, 86.6%, and 85.2% for SP-A; 69.7%, 95.1%, and 87.8% for SP-D; and 51.5%, 92.7%, and 80.9% for MCP-1; respectively. The serum levels of SP-A and SP-D, but not of KL-6, were significantly higher in patients with bacterial pneumonia than in healthy volunteers. These results suggest that of the markers studied, KL-6 is the best serum marker for ILD.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11818324     DOI: 10.1164/ajrccm.165.3.2107134

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  114 in total

1.  Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 40-2002. A 56-year-old man with rapidly worsening dyspnea.

Authors:  Michelle Ng Gong; Eugene J Mark
Journal:  N Engl J Med       Date:  2002-12-26       Impact factor: 91.245

2.  Interstitial Lung Disease in Idiopathic Inflammatory Myopathy.

Authors:  Lesley Ann Saketkoo; Dana P Ascherman; Vincent Cottin; Lisa Christopher-Stine; Sonye K Danoff; Chester V Oddis
Journal:  Curr Rheumatol Rev       Date:  2010-05

3.  Evaluation and management of pulmonary disease in ataxia-telangiectasia.

Authors:  Sharon A McGrath-Morrow; W Adam Gower; Cynthia Rothblum-Oviatt; Alan S Brody; Claire Langston; Leland L Fan; Maureen A Lefton-Greif; Thomas O Crawford; Michelle Troche; John T Sandlund; Paul G Auwaerter; Blaine Easley; Gerald M Loughlin; John L Carroll; Howard M Lederman
Journal:  Pediatr Pulmonol       Date:  2010-09

4.  Serum KL-6 levels in lung cancer patients with or without interstitial lung disease.

Authors:  Kunihiko Miyazaki; Koichi Kurishima; Katsunori Kagohashi; Mio Kawaguchi; Hiroichi Ishikawa; Hiroaki Satoh; Nobuyuki Hizawa
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

5.  Relationship between indium exposure and oxidative damage in workers in indium tin oxide production plants.

Authors:  Hung-Hsin Liu; Chang-Yun Chen; Gun-Ing Chen; Lien-Hsiung Lee; Hsiu-Ling Chen
Journal:  Int Arch Occup Environ Health       Date:  2011-08-11       Impact factor: 3.015

6.  Association of serum KL-6 levels with interstitial lung disease in patients with connective tissue disease: a cross-sectional study.

Authors:  Ekin Oktay Oguz; Orhan Kucuksahin; Murat Turgay; Mustafa Turgut Yildizgoren; Askin Ates; Nalan Demir; Ozlem Ozdemir Kumbasar; Gulay Kinikli; Nursen Duzgun
Journal:  Clin Rheumatol       Date:  2016-01-13       Impact factor: 2.980

Review 7.  Idiopathic Pulmonary Fibrosis: A Genetic Disease That Involves Mucociliary Dysfunction of the Peripheral Airways.

Authors:  Christopher M Evans; Tasha E Fingerlin; Marvin I Schwarz; David Lynch; Jonathan Kurche; Laura Warg; Ivana V Yang; David A Schwartz
Journal:  Physiol Rev       Date:  2016-10       Impact factor: 37.312

8.  Circulating KL-6 levels in patients with drug induced pneumonitis.

Authors:  H Ohnishi; A Yokoyama; Y Yasuhara; A Watanabe; T Naka; H Hamada; M Abe; K Nishimura; J Higaki; J Ikezoe; N Kohno
Journal:  Thorax       Date:  2003-10       Impact factor: 9.139

9.  Diagnosis of ovarian cancers using thoracoscopy: Three case reports and review of the literature.

Authors:  Makoto Nakao; Tetsuya Oguri; Mikinori Miyazaki; Takehiro Uemura; Osamu Takakuwa; Eiji Kunii; Hirotsugu Ohkubo; Ken Maeno; Shigeki Sato
Journal:  Exp Ther Med       Date:  2012-04-11       Impact factor: 2.447

10.  Involvement of pulmonary endothelial cell injury in the pathogenesis of pulmonary fibrosis: clinical assessment by 123I-MIBG lung scintigraphy.

Authors:  Noriaki Takabatake; Tsuyoshi Arao; Makoto Sata; Shuichi Abe; Sumito Inoue; Yoko Shibata; Yasuchika Takeishi; Isao Kubota
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-09-23       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.